December 1, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q4 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements, webinars...
December 12, 2025 Biomarker Data Repository Workshop First workshop in a series on the Biomarker Data Repository (BmDR). This inaugural workshop will feature presentations on BmDR...
October 30, 2025 Rare/Orphan and Pediatric Disease Program Webinar: Addressing the Lack of Standardized Laboratory Reference Ranges in Neonatal Trials: Pilot GUI Launch C-Path's International Neonatal Consortium hosts the webinar, "Addressing the Lack of Standardized..."
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 4, 2025 From Data to Hope: C-Path’s Polycystic Kidney Disease Outcomes Consortium and the Power of Data Sharing Every year on September 4, families, patients, advocates, and researchers come together to recognize Polycystic Kidney Disease...
September 8, 2025 Shaping the Future of AATD: Patient Perspectives to Drive the Next Decade of Innovation in Alpha-1 Antitrypsin Deficiency On September 8, C-Path and the Alpha-1 Foundation are co-hosting a virtual workshop, Shaping the Future of AATD: Patient...
July 15, 2025 Preventing, Delaying Type 1 Diabetes Critical Path Institute, which formed the T1D Consortium in 2017, is working to accelerate the process to new therapies...
July 14, 2025 Principles of good practice for concept definition in the context of translation and linguistic validation of clinical outcome assessments (COAs) Translation teams conducting translation and cultural adaptation find it paramount to properly describe concepts of items...
July 9, 2025 C-Path’s Kristen Swingle Named a “Woman Leading the Region” by BizTucson C-Path) is proud to announce that President and Chief Operating Officer Kristen Swingle, M.S., has been named a 2025 BizTucson..
May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
